Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

19th Cancer Research at Bath (CR@B) Symposium /
Current treatment for brain tumours

1st May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 02.05.19
Views: 639

Prof Mark Beresford - Royal United Hospital Bath, Bath, UK

Prof Mark Beresford speaks to ecancer at the 2019 Cancer Research At Bath conference about the treatment and management of brain tumours.

He outlines the current treatment regimen for brain tumour patients, and how this is slowly improving but still relatively poor in terms of survival.

Prof Beresford hopes that the Cancer Research At Bath conference will bring some new avenues and collaborations to pursue in order to improve these treatments.

He finishes by outlining some of the familial, financial, and social issues surrounding patients with brain cancer.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation